Abstract
When studying the pharmacological mediation of an inflammatory reaction, several difficulties are encountered. These lie in the multiplicity of factors involved and the complexity of their interactions. However, there are rigid criteria which ought to be satisfied before a substance can be definitely classified as a mediator of inflammation; these are listed below:
-
(1)
The putative mediator of inflammation should induce some or all of the signs of inflammation.
-
(2)
During the inflammatory reaction, the putative mediator should be released in amounts whose local concentrations in the tissue are capable of inducing these signs; ideally its appearance should correlate with development of the inflammatory reaction.
-
(3)
Release or actions of the putative mediator should be reduced by known anti-inflammatory drugs and, as a corollary, drugs which reduce the release or actions of the mediator should possess anti-inflammatory properties.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ambache, N., 1961, Prolonged erythema produced by chromatographically purified irin, J. Physiol. (London) 160:3.
Ambache, N., Brummer, M. C., Rose, S. G., and Whiting, J., 1966, Thin layer chromatography of spasmogenic unsaturated hydroxy acids from various tissues, J. Physiol. (London) 185:77.
Ambache, N., Kavanagh, L., and Whiting, J., 1965, Effect of mechanical stimulation on rabbits’ eyes: release of active substances in anterior chamber perfusates, J. Physiol. (London) 176:378.
Anderson, A. J., 1970, Lysosomal enzyme activity in rats with adjuvant-induced arthritis, Ann. Rheum. Dis. 29:307.
Anderson, A. J., Brocklehurst, W. E., and Willis, A. L., 1971, Evidence for the role of lysosomes in the formation of prostaglandins during carrageenin-induced inflammation in the rat. Pharm. Res. Commun. 2:13.
Anggard, E., and Jonsson, C. E., 1971, Efflux of prostaglandins in lymph from scalded tissue. Acta. Physiol. Scand. 81:440.
Arora, S., Lahiri, P. K., and Sanyal, R. K., 1970, The role of prostaglandin E(1) in inflammatory process in the rat. Int. Arch. Allergy, 39:186.
Bartels, J., Kunze, H., Vogt, W., and Wille, G., 1970, Prostaglandin liberation from and formation in trog intestine, Nuanyn-Schmiedeberg’s Arch. Pharmak. Exp. Path. 206:199.
Beitch, B. R., and Eakins, K. E., 1969, The effects of prostaglandins on the intraocular pressure of the rabbit, Br. J. Pharmac. 37:158.
Bergstrom, S., Carlsson, L. A., Ekelund, L. G., and Oro, L., 1965, Cardiovascular and metabolic response to infusions of prostaglandin E(1) and to simultaneous infusions of noradrenaline and prostaglandin E(1) in man, Acta. Physiol. Scand. 64:332.
Bergstrom, S., Carlsson, L. A., and Weeks, J. P., 1968, The prostaglandins: A family of biologically active lipids, Pharmac. Rev. 20:1.
Bergstrom, S., Danielsson, H., and Samuelsson, B., 1964, The enzymatic formation of prostaglandin E(2) from arachidonic acid, Biochim. Biophys. Acta. 90:207.
Bethel, R. A., and Eakins, K. E., 1971, Antagonism by polyphloretin phosphate of the intraocular pressure rise induced by prostaglandins and formaldehyde in the rabbit eye, Fed. Proc. 30:626.
Bonta, I. L., and De Vos, C. J., 1965, Presence of a slow contraction inducing material in fluid collected from the rat paw edema induced by serotonin, Experientia, 21:34.
Brittain, R. T., 1966, The intracerebral effects of noradrenaline and its modification by drugs in the mouse, J. Pharm. Pharmac. 18:621.
Cashin, C. H., and Heading, C. E., 1968, The assay of antipyretic drugs in mice, using intracerebral injection of pyretogenins, Br. J. Pharmac. 34:148.
Collier, H. O. J., 1971, Prostaglandins and aspirin, Nature (London) 232:17.
Coppi, G., and Bonardi, G., 1968, Effect of two nonsteroidal anti-inflammatory agents on alkaline and acid phosphatases of inflamed tissue, J. Pharm. Pharmac. 20:661.
Crunkhorn, P., and Willis, A. L., 1969, Actions and interactions of prostaglandins administered intradermally in rat and man, Br. J. Pharmac. 36:216.
Crunkhorn, P., and Willis, A. L., 1971a, Cutaneous reactions to intradermal prostaglandins, Br. J. Pharmac. 41:49.
Crunkhorn, P., and Willis, A. L., 1971b, Interaction between prostaglandins E and F given intradermally in the rat, Br. J. Pharmac. 41:507.
DiRosa, M., Giroud, J. P., and Willoughby, D. A., 1971, Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turpentine, J. Path. 104:15.
DiRosa, M., and Willoughby, D. A., Screens for antiinflammatory drugs, J. Pharm. Pharmac. 23:297.
Eisen, V., Greenbaum, L., and Lewis, G. P., 1968, Kinins and anti-inflammatory steroids, Br. J. Pharmac. 34:169.
Elsbach, P., 1966, Phospholipid metabolism by phagocytic cells, I. A comparison of conversion of [32P]-lysolecithin to lecithin by homogenates of rabbit polymorphonuclear leukocytes and alveolar macrophages, Biochim. Biophys. Acta 125:510.
Elsbach, P., and Rizack, M. A., 1963, Acid lipase and phospholipase activity in homogenates of rabbit polymorphonuclear leukocytes, Am. J. Physiol. 205:115.
Feldberg, W., and Saxena, P. N., 1971, Fever produced in rabbits and cats by prostaglandin E(1) injected into the cerebral ventricles, J. Physiol. 215:23.
Ferreira, S. H., Moncada, S., and Vane, J. R., 1971, Indomethacin and aspirin abolish prostaglandin release from spleen. Nature New Biology, 231:237.
Fowler, S., and De Duve, C., 1969, Digestive activity of lysosomes. III. The digestion of lipids by extracts of rat liver lysosomes, J. Biol. Chem. 244:471.
Gardner, D. L., 1960, Production of arthritis in the rabbit by the local injection of the mucopolysaccharide carrageenin, Ann. Rheum. Dis. 19:369.
Giroud, J. P., and Willoughby, D. A., 1970, The interrelations of complement and a prostaglandin-like substance in acute inflammation, J. Path. 101:241.
Glenn, M. E., 1972, Pro-inflammatory and anti-inflammatory effects of certain prostaglandins, in “Prostaglandins in Cellular Biology and the Inflammatory Process” (B. B. Pharriss and P. W. Ramwell, eds.). Plenum Press, New York (in press).
Greaves, M. W., Sondergaard, J., and McDonald-Gibson, W., 1971, Recovery of prostaglandins in human cutaneous inflammation, Br. Med. J., 2: 258.
Green, K., and Samuelsson, B., 1964, Prostaglandins and related factors: XIX, Thin layer chromatography of prostaglandins, J. Lipid. Res. 5:117.
Harris, J. M., and West, G. B., 1963, Rats resistant to the dextran anaphylactoid reactions, Br. J. Pharmac. 20:550.
Holmes, S. W., 1968, Concentrations of prostaglandins in the nervous system. Ph. D. Thesis in the University of London.
Holmes, S. W., 1970, The spontaneous release of prostaglandins into the cerebral ventricles of the dog and the effect of external factors on this release, Br. J. Pharmac. 38:653.
Holmsen, H., and Day, H. J., 1970, The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents, J. Lab. Clin. Med. 75:840.
Horton, E. W., 1963, Action of prostaglandin E(1) on tissues which respond to bradykinin, Nature (London) 200:892.
Juhlin, S., and Michaelsson, G., 1969, Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis, Acta. Derm-Vener. (Stockholm) 49:251.
Kaley, G., and Weiner, R., 1968, Microcirculatory studies with prostaglandin E(1), in “Prostaglandin”, symposium of the Worcester Foundation for Experimental Biology, (P. W. Ramwell and J. E. Shaw, eds.), Interscience, New York, pp. 321–328.
Kaley, G., and Weiner, R., 1971, Prostaglandin E(1): a potential mediator of the inflammatory response, Ann. N. Y. Acad. Sci. 180:338.
Melmon, K. L., and Cline, M. J., 1967, Interaction of plasma kinins and granulocytes. Nature, (London) 213:90.
Michaelsson, G., 1970, Effects of antihistamines, acetylsalicylic acid and prednisone on cutaneous reactions to kallikrein and prostaglandin E(1), Acta- Derm. Vener. (Stockholm) 30:31.
Milton, A. S., and Wendlandt, S., 1970, A possible role for prostaglandin E(1) as a modulator for temperature regulation in the central nervous system of the cat, J. Physiol. Lond. 202:768.
Milton, A. S., and Wendlandt, S., 1971, J. Physiol. (London) 218:325.
Muller-Eberhard, H. J., 1969, Complement, Ann. Rev. Biochem. 38:389.
Parrat, J. R., and West, G. B., 1958, Inhibition by various substances of edema formation in the hind paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, eggwhite, and compound 48/80, Br. J. Pharmac., 13:65.
Piper, P. J., and Vane, J. R., 1969, Release of additional factors in anaphylaxis and its antagonism by antiinflammatory drugs. Nature (London) 225:29.
Samuelsson, B., 1963, Isolation and identification of prostaglandins from human seminal plasma, J. Biol. Chem. 238:3229.
Selye, H., 1954, An experimental model illustrating the pathogenesis of the diseases of adaptation, J. Clin. Endocrin., 14:997.
Shaw, J. E., and Ramwell, P. W., 1969, Separation, identification and estimation of prostaglandins, Meth. Biochem. Analysis, 17:325.
Silver, M. J., Smith, J. B., and Webster, G. R., 1971, Phospholipase activity in human platelets, Pharmacologist, 13(2):276, abs. 474.
Smith, A. D., and Winkler, H., 1968, Lysosomal phospholipases A(1) and A(2) of bovine adrenal medulla, Biochem. J., 108:867.
Smith, J. B., and Willis, A. L., 1970, Formation and release of prostaglandins by platelets in response to thrombin, Br. J. Pharmac. 40:545.
Smith, J. B., and Willis, A. L., 1971, Aspirin selectively inhibits prostaglandin production in human platelets, Nature New Biology, 231: 235.
Smith, M. J. H., and Dawkins, P. D., 1971, Salicylate and enzymes, J. Pharm. Pharmac. 32:729.
Solomon, L. M., Juhlin, L., and Kirschbaum, M. B., 1968, Prostaglandin on cutaneous vasculature, J. Invest. Derm. 51: 280.
Spector, W. G., and Willoughby, D. A., 1968, The pharmacology of inflammation, English universities Press Ltd. (London).
van Arman, C. G., Begany, A. J., Miller, L. M., and Pless, H. H., 1965, Some details of the inflammations caused by yeast and carrageenin, J. Pharmac. Exp. Ther. 150:328.
Vane, J. R., 1964, The use of isolated organs for detecting active substances in the circulating blood, Br. J. Pharmac. Chemother. 23:360.
Vane, J. R., 1971, Inhibition of prostaglandin synthesis as a mechanism of action from aspirin-like drugs, Nature New Biology, 231:232.
Vargaftig, B. B., and Dao, N., Pharmacology, (in press).
Waite, M., Scherphof, G. L., and Van Deenen, L. L. M., 1969, Differentiation of phospholipases A in mitochondria and lysosomes of rat liver, J. Lipid Res. 10:411.
Waitzman, M. B., and King, C. D., 1967, Prostaglandin influences on intraocular pressure and pupil size. Am. J. Physiol. 212:329.
Weissman, G., 1967, The role of lysosomes in inflammation and disease, Ann. Rev. Med. 18:97.
Weissman, G., and Thomas, L., 1964, The effect of corticosteroids upon connective tissue and lysosomes, Recent Progr. Horm. Res. 20:215.
Willis, A. L., 1969a, Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion, J. Pharm. Pharmac. 21:126.
Willis, A. L., 1969b, Release of histamine, kinin and prostaglandins during carrageenin-induced inf lairmation in the rat, in “Prostaglandins Peptides and Amines”, (P. Mantegazza and E. W. Horton, eds.), Academic Press, London. pp. 31–38.
Willis, A. L., 1970, Identification of prostaglandin E(2) in rat inflammatory exudate, Pharmac. Res. Commun. 2:297.
Willis, A. L., 1971, Prostaglandins: their release and inter-relationship with biogenic amines. Ph. D. Thesis in the University of London.
Willis, A. L., Davison, P., and Ramwell, P. W., 1972, An action of antipyretic drugs in mice through inhibition of prostaglandin synthesis in brain, in “Prostaglandins” (in press).
Willoughby, D. A., Coote, E., and Turk, J. L., 1969, Complement in acute inflammation, J. Path. 97:295.
Winter, C.A., Risley, E. A., and Nuss, G. V., 1962, Carrageenin-induced edema in hind paws of the rat as an assay for anti-inflammatory drugs, Proc. Soc. Exp. Biol. Med. 111:544.
Winter, C. A., Risley, E. A., and Nuss, G. V., 1963, Antiinflammatory and antipyretic activities of indomethacin, 1 (p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid, J. Pharmac. Exp. Ther. 141:369.
Wiseman, E. H., and Chang, Y., 1968, The role of fibrin in the inflammatory response to carrageenin, J. Pharmac. Exp. Ther. 159:206.
Woodbury, D. M., 1970, Analgesic-antipyretics, antiinflammatory agents and inhibitors of uric acid synthesis, in “Pharmacological Basis of Therapeutics”, 4th edn. (L. S. Goodman and A. Gilman, eds.), The MacMillan Company, London and Toronto, pp. 314–347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Plenum Press, New York
About this paper
Cite this paper
Willis, A.L., Davison, P., Ramwell, P.W., Brocklehurst, W.E., Smith, B. (1972). Release and Actions of Prostaglandins in Inflammation and Fever: Inhibition by Anti-Inflammatory and Antipyretic Drugs. In: Ramwell, P.W., Pharriss, B.B. (eds) Prostaglandins in Cellular Biology. Alza Conference Series, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-2844-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2844-5_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-2846-9
Online ISBN: 978-1-4684-2844-5
eBook Packages: Springer Book Archive